Chronic treatment regimen using glucagon-like insulinotropic peptides

Chronic treatment regimen using glucagon-like insulinotropic peptides

  • CN 1,501,809 A
  • Filed: 12/07/2001
  • Published: 06/02/2004
  • Est. Priority Date: 12/13/2000
  • Status: Active Application
First Claim
Patent Images

1. method that makes blood sugar level normalization;

  • this method comprises makes GLP-1 analog or derivant with biologically active form;

    state blood plasma level steady in a long-term is maintained about 60pmol/l between about 200pmol/l, and described biologically active form is in Val in external effectiveness 8-GLP-1 (7-37) OH is in the vitro efficacy twice, and wherein said GLP-1 analog or derivant are used by subcutaneous injection, and per 24 hours only once or twice.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×